Related references
Note: Only part of the references are listed.Residual Cardiovascular Risk at Low LDL: Remnants, Lipoprotein(a), and Inflammation
Ron C. Hoogeveen et al.
CLINICAL CHEMISTRY (2021)
Advances in biological therapies for dyslipidemias and atherosclerosis
Eftaxia-Konstantina Valanti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Vera A. Bittner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
Sotirios Tsimikas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
Andreja Rehberger Likozar et al.
ANNALS OF MEDICINE (2020)
What do we know about the role of lipoprotein(a) in atherogenesis 57 years after its discovery?
Barbara Cybulska et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease A Prespecified Secondary Analysis of the ACCELERATE Trial
Rishi Puri et al.
JAMA CARDIOLOGY (2020)
Prognostic utility of lipoprotein(a) combined with fibrinogen in patients with stable coronary artery disease: a prospective, large cohort study
Yan Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Looking at Lp(a) and Related Cardiovascular Risk: from Scientific Evidence and Clinical Practice
Thomas M. Stulnig et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Small size apolipoprotein(a) isoforms enhance inflammatory and proteolytic potential of collagen-primed monocytes
Nadia Sabbah et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial
Kausik K. Ray et al.
JAMA CARDIOLOGY (2019)
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial
Michelle L. O'Donoghue et al.
CIRCULATION (2019)
Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction
Enas A. Enas et al.
INDIAN HEART JOURNAL (2019)
Recurrent coronary syndromes in a patient with isolated very-high lipoprotein (a) and the prothrombin genetic variant rs1799963 (G20210A): a case report
Ilya Khantalin et al.
EUROPEAN HEART JOURNAL-CASE REPORTS (2019)
Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification
Ugur Ozkan et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2019)
Lipoprotein(a): A missing culprit in the management of athero-thrombosis?
Gianna Ferretti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins Prespecified Secondary End Points in ORION 1
Kausik K. Ray et al.
CIRCULATION (2018)
Atherosclerosis and inflammation: overview and updates
Glaucylara Reis Geovanini et al.
CLINICAL SCIENCE (2018)
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
Nancy R. Cook et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
Peter Willeit et al.
LANCET (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis
Richard G. Jung et al.
THROMBOSIS JOURNAL (2018)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms
G. Kees Hovingh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a)
C. A. Scipione et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity
Matteo Pirro et al.
PHARMACOLOGICAL RESEARCH (2017)
Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9
Kazuhiko Kotani et al.
JOURNAL OF THORACIC DISEASE (2017)
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Michael B. Boffa et al.
JOURNAL OF LIPID RESEARCH (2016)
Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals The Multi-Ethnic Study of Atherosclerosis
Jing Cao et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
K. H. Bonaa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis
Hong Wang et al.
G3-GENES GENOMES GENETICS (2016)
High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study
Anne Langsted et al.
LANCET DIABETES & ENDOCRINOLOGY (2016)
Lipoprotein (a) as a risk factor for ischemic stroke: A meta-analysis
Alexander H. Nave et al.
ATHEROSCLEROSIS (2015)
Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100 578 Individuals from the General Population
Anne Langsted et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
Iain B. McInnes et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
Anne Langsted et al.
ATHEROSCLEROSIS (2014)
Genetic variants in PLG, LPA, and SIGLEC 14 as well as smoking contribute to plasma plasminogen levels
Qianyi Ma et al.
BLOOD (2014)
Lipoprotein(a) Levels, Genotype, and Incident Aortic Valve Stenosis A Prospective Mendelian Randomization Study and Replication in a Case-Control Cohort
Benoit J. Arsenault et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Inhibition of plasminogen activation by apo(a): role of carboxyl-terminal lysines and identification of inhibitory domains in apo(a)
Rocco Romagnuolo et al.
JOURNAL OF LIPID RESEARCH (2014)
Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a) Prospective 15-Year Outcomes in the Bruneck Study
Peter Willeit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Lipoprotein(a) Levels in Familial Hypercholesterolemia An Important Predictor of Cardiovascular Disease Independent of the Type of LDL Receptor Mutation
Rodrigo Alonso
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Lipoprotein (a), LPA Ile4399Met, and Fibrin Clot Properties
Charles M. Rowland et al.
THROMBOSIS RESEARCH (2014)
Association between baseline lipoprotein (a) levels and restenosis after coronary stenting: Meta-analysis of 9 cohort studies
Shan-yu Qin et al.
ATHEROSCLEROSIS (2013)
Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
Gregor Leibundgut et al.
JOURNAL OF LIPID RESEARCH (2013)
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma
Philipp Wiesner et al.
JOURNAL OF LIPID RESEARCH (2013)
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
Pia R. Kamstrup et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Drug-Eluting Coronary-Artery Stents
Giulio G. Stefanini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lipoprotein(a), Interleukin-10, C-Reactive Protein, and 8-Year Outcome After Percutaneous Coronary Intervention
Isabella Kardys et al.
CLINICAL CARDIOLOGY (2012)
Calcific Aortic Valve Disease: Not Simply a Degenerative Process A Review and Agenda for Research From the National Heart and Lung and Blood Institute Aortic Stenosis Working Group
Nalini M. Rajamannan et al.
CIRCULATION (2011)
The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles
Kiyohito Arai et al.
ATHEROSCLEROSIS (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
The prognostic value of biomarkers after a premature myocardial infarction
Javier Pineda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
The Mysteries of Lipoprotein(a) and Cardiovascular Disease Revisited
Stefan Kiechl et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Lipoprotein a: where are we now?
Konstantinos Tziomalos et al.
CURRENT OPINION IN CARDIOLOGY (2009)
Premature coronary artery disease in young (age <45) subjects: Interactions of lipid profile, thrombophilic and haemostatic markers
Javier Pineda et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
Pia R. Kamstrup et al.
CIRCULATION (2008)
Native, oxidized lipoprotein(a) and lipoprotein(a) immune complex in patients with active and inactive rheumatoid arthritis: Plasma concentrations and relationship to inflammation
Junjun Wang et al.
CLINICA CHIMICA ACTA (2008)
The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity
Sotirios Tsimikas et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
Claes Bergmark et al.
JOURNAL OF LIPID RESEARCH (2008)
New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease
Sotirios Tsimikas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
The molecular nature and consequences of lipoprotein (a)'s association with platelets
D. E. Barre
PROTEIN AND PEPTIDE LETTERS (2007)
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction
Walter Stefan Speidl et al.
THROMBOSIS RESEARCH (2007)
Association between inflammation, lipid and hemostatic factors in patients with stable angina
Jose D. Sagastagoitia et al.
THROMBOSIS RESEARCH (2007)
PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stenting
R Marcucci et al.
HEART (2006)
Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis:: serum levels and relationship to inflammation
D Dursunoglu et al.
RHEUMATOLOGY INTERNATIONAL (2005)
The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease
D Bilgen et al.
CLINICAL BIOCHEMISTRY (2005)
Effects of high plasma lipoprotein (a) levels on tissue factor pathway inhibitor and the protein C pathway
MD Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Lipoprotein(a): New insights into mechanisms of atherogenesis and thrombosis
A Deb et al.
CLINICAL CARDIOLOGY (2004)
Interactions between fibrinolysis, lipoproteins and leptin related to a first myocardial infarction
AM Thogersen et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2004)
Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetyllhydrolase
LD Tsironis et al.
CARDIOVASCULAR RESEARCH (2004)
The functions of plasminogen in cardiovascular disease
EF Plow et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2004)
Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease - a 13-year follow-up
A Niessner et al.
THROMBOSIS AND HAEMOSTASIS (2003)
Inhibition of plasminogen activation by lipoprotein(a) - Critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
MA Hancock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased plasminogen activator inhibitor-1 and apolipoprotein (a) in coronary atherectomy specimens in acute coronary syndromes
J Shindo et al.
CORONARY ARTERY DISEASE (2001)
Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina
P Bogaty et al.
CIRCULATION (2001)
Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed - Dynamic and structural approaches by confocal microscopy
JP Collet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
